Sangers Sequencing Service Market by Application and End User - Global Opportunity Analysis and Industry Forecast, 2013-2025

  • ID: 4580644
  • Report
  • Region: Global
  • 150 pages
  • Allied Analytics LLP
1 of 4
Sanger’s sequencing method is based on the principle of detecting labelled chain-terminating nucleotides, which are incorporated by a DNA polymerase during the replication of a template. This method of sequencing is also known as chain termination or dideoxy sequencing. The global Sanger’s sequencing service market was valued at $192 million in 2013, and is estimated to reach at $1,085 million by 2025, registering a CAGR of 14.2% from 2018 to 2025.

As Sanger’s sequencing is known as the gold standard of sequencing technologies, as it offers long read capability and a high-degree of accuracy. Sanger’s sequencing services are routinely offered by sequencing companies to different end users such as academic institutes and hospitals for sequence analysis.

Advantages associated with Sanger’s sequencing, technological advancements in sequencing procedures, and surge in application of Sanger’s sequencing are the key factors that boost market growth. Furthermore, increase in genome mapping programs; rise in awareness pertaining to DNA sequencing; and increase in investment in research, development, & innovation have bolstered the market growth.

However, dearth of skilled professionals and standardization concerns in sequencing procedures impede the market growth. Conversely, the use of cloud computing as a potential data management service and high growth potential in untapped emerging countries are anticipated to offer lucrative opportunities for market players in the near future.

The Sanger’s sequencing service market is segmented based on application, end user, and region. By application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. Deepening on end user, it is fragmented into academic & government research institutes, pharmaceuticals companies, biotechnology companies and hospitals & clinics. Region wise, the market is classified into the following regions, namely, the United States, EU, Japan, China, India, Southeast Asia, and rest of the world (ROW).

KEY BENEFITS
  • This report entails a detailed quantitative analysis of the current market trends and future estimations from 2013 to 2025 to identify the prevailing opportunities.
  • Sanger’s sequencing service market size and market estimations are based on comprehensive analysis of the applications, end users, and developments in the industry.
  • In-depth analysis based on region assists to understand the regional market and the strategic business planning.
  • The development strategies adopted by key market players are enlisted to understand the competitive scenario of the market
KEY MARKET SEGMENTS

By Application
  • Diagnostics
  • Biomarkers & Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Others
By End User
  • Academic & Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals & Clinics
By Region
  • United States
  • EU
  • Japan
  • China
  • India
  • Southeast Asia
  • Rest of the World (ROW)
The list of key players operating in this market includes:
  • Source BioScience
  • GenScript Biotech Corporation
  • Thermo Fisher Scientific, Inc.
  • LGC Science Group Limited
  • Fasteris SA
  • CeMIA SA
  • Quintara Biosciences
  • GenHunter Corporation
  • Eurofins Scientific SE
  • GENEWIZ
  • Nucleics
  • SciGenom Labs Pvt. Limited
  • Microsynth AG. Inc.
The other players included in the value chain analysis (and not included in the report) include:
  • Laragen, Inc.
  • StarSEQ GmbH
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market scope and definition
3.2. Competitive environment analysis
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning, 2016
3.4. Patent analysis, 2010-2018
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Technological advancements in Sangers sequencing
3.5.1.2. Surge in applications of Sangers sequencing
3.5.1.3. Increase in genome mapping programs
3.5.2. Restraints
3.5.2.1. Lack of skilled professionals
3.5.2.2. Standardization concerns over sequencing-based diagnostics
3.5.3. Opportunities
3.5.3.1. Cloud computing serves as a potential data management service
3.5.3.2. Lucrative opportunities in the emerging markets

CHAPTER 4: GLOBAL AND REGIONAL SANGERS SEQUENCING SERVICE MARKET SHARE ANALYSIS
4.1. Global Sangers sequencing services market share analysis, 2017
4.2. U.S. Sangers sequencing services market share analysis, 2017
4.3. Europe Sangers sequencing services market share analysis, 2017
4.4. Japan Sangers sequencing services market share analysis, 2017
4.5. China Sangers sequencing services market share analysis, 2017
4.6. India Sangers sequencing services market share analysis, 2017
4.7. South-East Asia Sangers sequencing services market share analysis, 2017
4.8. Rest of the world Sangers sequencing services market share analysis, 2017

CHAPTER 5: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Diagnostics
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region
5.3. Biomarkers & cancer
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region
5.4. Reproductive health
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region
5.5. Personalized medicine
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region
5.6. Forensics
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region

CHAPTER 6: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Academic & government research institutes
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by region
6.3. Pharmaceutical companies
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by region
6.4. Biotechnology companies
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by region
6.5. Hospitals & clinics
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by region

CHAPTER 7: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. U.S.
7.2.1. Key market trends
7.2.2. U.S. market size and forecast
7.2.2.1. U.S. Sangers sequencing service market, by application
7.2.2.2. U.S. Sangers sequencing service market, by end user
7.3. Europe
7.3.1. Key market trends
7.3.2. Europe market size and forecast
7.3.2.1. Europe Sangers sequencing service market, by application
7.3.2.2. Europe Sangers sequencing service market, by end user
7.4. Japan
7.4.1. Key market trends
7.4.2. Japan market size and forecast
7.4.2.1. Japan Sangers sequencing service market, by application
7.4.2.2. Japan Sangers sequencing service market, by end user
7.5. China
7.5.1. Key market trends
7.5.2. China market size and forecast
7.5.2.1. China Sangers sequencing service market, by application
7.5.2.2. China Sangers sequencing service market, by end user
7.6. India
7.6.1. Key market trends
7.6.2. India market size and forecast
7.6.2.1. India Sangers sequencing service market, by application
7.6.2.2. India Sangers sequencing service market, by end user
7.7. Southeast Asia
7.7.1. Key market trends
7.7.2. Southeast Asia market size and forecast
7.7.2.1. Southeast Asia Sangers sequencing service market, by application
7.7.2.2. Southeast Asia Sangers sequencing service market, by end user
7.8. Rest of the world
7.8.1. Key market trends
7.8.2. Rest of the world market size and forecast
7.8.2.1. Rest of the world Sangers sequencing service market, by application
7.8.2.2. Rest of the world Sangers sequencing service market, by end user

CHAPTER 8: COMPANY PROFILES
8.1. CeMIA SA
8.1.1. Company Profile
8.1.2. Main business/business overview
8.1.3. Products, services, and solutions
8.1.4. CeMIA Revenue (Million USD)
8.2. Fasteris SA
8.2.1. Company Profile
8.2.2. Main business/business overview
8.2.3. Products, Services, and Solutions
8.2.4. Fasteris revenue (million USD)
8.3. GENEWIZ, Inc.
8.3.1. Company Profile
8.3.2. Main business/business overview
8.3.3. Products, services, and solutions
8.3.4. GENEWIZ Revenue (Million USD)
8.3.5. Recent developments
8.4. GenHunter Corporation
8.4.1. Company Profile
8.4.2. Main business/business overview
8.4.3. Products, Services, and Solutions
8.4.4. GenHunter revenue (million USD)
8.5. Genscript Biotech Corporation
8.5.1. Company Profile
8.5.2. Main Business/Business Overview
8.5.3. Products, Services, and Solutions
8.5.4. GenScript revenue (million USD)
8.6. LGC Science Group Holdings Limited
8.6.1. Company Profile
8.6.2. Main Business/Business Overview
8.6.3. Products, Services, and Solutions
8.6.4. LGC revenue (million USD)
8.6.5. Recent developments
8.7. Microsynth AG
8.7.1. Company Profile
8.7.2. Main business/business overview
8.7.3. Products, Services, and Solutions
8.7.4. Microsynth revenue (million USD)
8.8. Nucleics Pty. Ltd.
8.8.1. Company Profile
8.8.2. Main Business/Business Overview
8.8.3. Products, Services, and Solutions
8.8.4. Nucleics revenue (million USD)
8.9. Quintara Biosciences
8.9.1. Company Profile
8.9.2. Main Business/Business Overview
8.9.3. Products, Services, and Solutions
8.9.4. Quintara revenue (million USD)
8.9.5. Recent Developments
8.10. SciGenom Labs Pvt. Ltd.
8.10.1. Company Profile
8.10.2. Main business/business overview
8.10.3. Products, Services, and Solutions
8.10.4. SciGenom Labs revenue (million USD)
8.11. Source BioScience Plc
8.11.1. Company Profile
8.11.2. Main business/business overview
8.11.3. Products, services, and solutions
8.11.4. Source BioScience revenue (million USD)
8.12. Thermo Fisher Scientific Inc.
8.12.1. Company Profile
8.12.2. Main business/business overview
8.12.3. Products, services, and solutions
8.12.4. Thermo Fisher revenue (million USD)
8.12.5. Recent developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, "Sangers Sequencing Service Market by Application and End User: Global Opportunity Analysis and Industry Forecast, 2013-2025.The global Sangers sequencing service market was valued at $192 million in 2013, and is projected to reach $1,085 million by 2025, at a CAGR of 14.2% from 2018 to 2025. The growth of the market is driven by factors such as increase in the usage and applications of Sangers sequencing, especially in oncology research, diagnostics, reproductive health, and others. Furthermore, the market for Sangers sequencing services has witnessed tremendous growth in the recent years, due to upsurge in demand for this technique in genomics, transcriptomics, and other life science-related research areas.

The key drivers of the global Sangers sequencing service market are surge in technological advancements, especially microfluidic Sangers sequencing and rise in the number of collaborations & partnerships to promote the use of DNA sequencing in hospitals & research centers. In addition, heavy inflow of investment in R&D activities has facilitated the propagation of Sangers sequencing services, thereby providing lucrative opportunities for the market players. However, concerns related to accuracy & standardization and dearth of skilled professionals hamper the market growth.

Sangers sequencing has the potential to precisely differentiate between the genetic variations and facilitate the generation of potent biomarkers for medicine and disease diagnosis. In addition, low sequencing time, concise protocol length, and rise in cost of sequencing have increased its usage in biomarker discovery and cancer. The global biomarker & cancer Sangers sequencing service market is expected to reach $390 million by 2025.

Among the different end users, academic & government research institutes nearly occupied one-third share in the global Sangers sequencing service market in 2013. This is attributed to the fact that Sangers sequencing services have the capability to provide precise genomic information without the high costs associated with other methods of sequencing.

The United States was the leading revenue contributor to the global market in 2013, occupying nearly half of the total market share owing to high adoption rate of technologically advanced Sanger sequencing services. However, China is expected to grow at the highest CAGR of 17.2% from 2018 to 2025, owing to increase in disposable income; surge in research, development, & innovation activities; and growth in awareness of Sangers sequencing.

Key findings of the Sangers Sequencing Service Market:

EU accounted for more than one-third of the share of the Sangers sequencing service market in 2013.
The personalized medicine application segment is anticipated to grow with the highest CAGR throughout the forecast period.
Academic and government research institutes accounted for nearly one-third of the global Sangers sequencing service market in 2013.
China is anticipated to grow at the highest rate in the market during the analysis period.

The report provides extensive competitive analysis and profiles of key market players such as Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Nucleics, SciGenom Labs Pvt. Limited, and Microsynth AG. Inc. The other players in the value chain (not included in the report) include Laragen, Inc. and StarSEQ GmbH.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll